The Agricultural Bank of China is piloting facial recognition scanners on two of its ATM machines in Guiyang, southwest China's Guizhou province. Sometimes referred to as "Smile to Pay" technology, this ATM lets you smile to get paid. Shandong Business Daily reports users can withdraw money from the ATM machines by looking into a camera to have their facial features scanned. The scanners feature infrared cameras that can tell a real human face apart from pictures and masks. In addition to scanning their faces, users will have to type in their cell phone and ID numbers to get the money. They can withdraw a maximum of 3,000 yuan per day through facial recognition ATMs. The bank is aiming to have facial scanners installed on all of its ATM machines across Guizhou by the end of this year. The Agricultural Bank already has these scanners at 37 of its bank counters across China. The scanners are also featured at the Merchants Bank's ATM machines in 106 cities across China. Face scanning is widely applied in China. In addition to withdrawing money, it can help make payments at fast-food restaurants, checking in at various hotels and other parts of traveling both easier and faster. material braceletscheap custom wristbandsfidget spinner braceletdebossed wristbandrubber arm bandsjordan wristband rubber
BEIJING -- China is working to reduce the prices of cancer drugs and the financial burden on patients, according to health officials Saturday. Prices of cancer drugs will be reduced through centralized negotiations and procurement, Zeng Yixin, vice director of the National Health Commission, said at a press conference. According to Chen Jinfu, head of the medical insurance department of the Ministry of Human Resources and Social Security, last year the government reached agreements with pharmaceutical enterprises on the prices of 36 cancer medicines on the medical insurance list. Prices of these drugs have been marked down by 44 percent on average, Chen said. Stressing a patient-centered approach in negotiations, the official also noted that market competition is also needed. The government will work to include more antineoplastic drugs into the country's catalogue of medical insurance reimbursement, which already incorporates most of the relevant drugs. Moreover, efforts have been made in accelerating the review and approval procedures for new medicines, reducing circulation costs and improving diagnosis to reduce the burden on patients and their families, Zeng said. The average approval time for imported drugs has been significantly shortened, and the customs clearance procedures streamlined, said Li Jinju, an official with China Food and Drug Administration. The Ministry of Finance announced Monday that China will exempt 28 drugs from import tariffs, including all cancer drugs from May 1, as part of wider opening of the market. Admitting that the tariff cut may challenge China's domestic pharmaceutical industry, Liu Dengfeng of the health commission expressed confidence in tackling it. China's medical research and development has progressed in recent years with the talent pool getting stronger and innovation booming, he said.
